Tokyo Tape
Sign in

Otsuka Holdings

4578.TPharmaceutical
Financials · Consolidated
ConsolidatedStandalone
Fiscal year ended2025-122024-122023-122022-122021-122020-12
Revenue¥2.47T¥2.33T¥2.02T¥1.74T¥1.50T¥1.42T
Operating income¥479.4bn¥323.6bn¥139.6bn¥150.3bn¥154.5bn—
Net income (owners)¥363.1bn¥343.1bn¥121.6bn¥133.9bnr¥125.5bn¥148.1bn
Total assets¥4.20T¥3.74T¥3.36T¥3.10Tr¥2.82T¥2.63T
Net assets / equity¥3.10T¥2.78T¥2.44T¥2.26Tr¥2.05T¥1.88T
Operating cash flow¥403.6bn¥354.6bn¥283.2bn¥211.8bn¥228.9bn¥232.8bn
EPS (basic)¥685.06¥633.76¥224.1¥246.8r¥231.32¥273.15

From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.

Reports · 13
AllAnnual 4Half-year 3Quarterly 620262025202420232022
PeriodFormFiledFigures
2026-01-01 → 2026-06-30Half-year2026-07-3181 figures · EDINET
2025-01-01 → 2025-12-31Annual2026-03-26207 figures · EDINET
2025-01-01 → 2025-06-30Half-year2025-07-3181 figures · EDINET
2024-01-01 → 2024-12-31Annual2025-03-31208 figures · EDINET
2024-01-01 → 2024-06-30Half-year2024-08-02101 figures · EDINET
2024-01-01 → 2024-03-31Quarterly Q12024-04-3086 figures · EDINET
2023-01-01 → 2023-12-31Annual2024-03-29217 figures · EDINET
2023-01-01 → 2023-09-30Quarterly Q32023-10-31114 figures · EDINET
2023-01-01 → 2023-06-30Quarterly Q22023-07-31114 figures · EDINET
2023-01-01 → 2023-03-31Quarterly Q12023-05-1286 figures · EDINET
2022-01-01 → 2022-12-31Annual2023-03-31217 figures · EDINET
2022-01-01 → 2022-09-30Quarterly Q32022-11-02114 figures · EDINET
2022-01-01 → 2022-06-30Quarterly Q22022-08-03114 figures · EDINET

22 more reports are still being processed.

Segments · FY ended 2025-12
SegmentExternal salesProfit
Consumer Products¥34.6bn¥25.1bn
Nutraceuticals¥577.6bn¥57.7bn
Other¥112.4bn¥8.0bn
Pharmaceuticals¥1.74T¥445.3bn
Adjustments & eliminations—−¥56.8bn
Total¥2.47T¥536.2bn

Segment names from EDINET member IDs; not mapped to a common taxonomy.